Burrill & Co. and the Infinity Group are joining forces to pursue investments in Chinese life science companies.
San Francisco-based Burrill, a venture capital/private equity player that’s also trying to launch a $1 billion investment fund in Minnesota, and Israel- and China-based Infinity will co-invest in U.S. dollars and Chinese renminbi as equal partners, according to a press release.
The deal calls for Burrill to establish headquarters for its China operations in Hong Kong, where Infinity already has operations. The JV will also take advantage of Infinity’s 10 offices in the People’s Republic and others in the U.S., Europe and Asia.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
For Infinity it’s a chance to broaden its American footprint, aiming to introduce Israeli, U.S. and European technologies in China.
“We are very excited about this joint venture as this partnership will be able to build upon our complementary focus areas internationally,” Burrill & Co. CEO Steven Burrill said in prepared remarks. “We will be able to bring our venture capital/private equity operations with our focus on innovation to delivery in healthcare, as well as activities in life sciences publications and events to Infinity’s extensive operations and networks in China.”
Burrill is the San Francisco-based biotech investor who is trying to create a $1 billion investment fund to back the Elk Run BioBusiness Park in Pine Island, Minnesota.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
